SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
Vertex announces the FDA has accepted the application and granted Priority Review for our fifth investigational CFTR modulator
We presented new data at the 2024 American Diabetes Association Scientific Sessions on our investigational program for type 1 diabetes
We announced new data at the 2024 European Hematology Association Congress on our treatment for sickle cell disease and beta thalassemia
Vertex presents new data at the European Cystic Fibrosis Conference demonstrating the safety and efficacy of treatment with our fourth cystic fibrosis medicine
Jennifer Schneider elected to Vertex Board of Directors
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Find a Vertex clinical trial
Volunteers who participate in clinical trials
help make new medicines a reality.
Featured Stories